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produce distinct sets of LC-PUFA-derived epoxy- and hy-
droxy-metabolites, collectively termed CYP eicosanoids. In 
mammals, these metabolites serve as second messengers of 
numerous hormones, growth factors, and cytokines that 
regulate vascular, cardiac, and renal function ( 3 ). Imbal-
ances in CYP-eicosanoid formation are linked to the devel-
opment of cardiovascular disease, infl ammatory disorders, 
and cancer ( 3–5 ). Similar to mammals, the nematode 
 Caenorhabditis elegans (Maupas, 1900) produces arachidonic 
acid (AA)- and EPA-derived CYP eicosanoids ( 6 ). CYP-33E2, 
CYP-29A3, and EMB-8, the worm’s NADPH-CYP reductase 
(CPR), have been identifi ed as contributing enzymes ( 6 ). 
CYP-33E2 prefers EPA over AA and generates 17,18-
epoxyeicosatetraenoic (17,18-EEQ) as main EPA-derived 
metabolite ( 7 ). CYP2J2, a major epoxygenase in the heart, 
is the most closely related human homolog of CYP-33E2. 
CYP-29A3 presumably contributes to hydroxy-metabolite 
formation and shows sequence homology to mammalian 
CYP4 family members that produce 20-HETE as their 
main AA-derived metabolite ( 6 ). 
 C. elegans allows genetic dissection of the physiological 
functions of various PUFAs and their metabolites, with a 
resolution not possible in mammals ( 8 ). Mammals must 
obtain n-6 and n-3 PUFAs from the diet, whereas  C. elegans 
endogenously produces both PUFA classes. Key genes 
present in  C. elegans , but not in mammals, encode   -12 
( fat-2 ) and n-3 fatty acyl desaturases ( fat-1 ). In concert with 
further desaturases and elongases,  fat-2 and  fat-1 establish 
a biosynthetic pathway from oleic (18:1 n-9), via linoleic 
acid (LA; 18:2 n-6) and   -linolenic acid (ALA; 18:3 n-6), to 
AA (20:4 n-6) and EPA (20:5 n-3) ( 8, 9 ). Mutations in  fat-2 
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0.8 mM isopropyl-  -D-thiogalactopyranosid (IPTG) .  E. coli HT115 
bacteria containing RNAi vectors expressing double-stranded 
RNA of the genes  cyp-29A3 and  cyp-33E2 , respectively, were pre-
cultured, induced with IPTG and fi nally used as nematode food 
as described previously ( 6 ). 
 Chemicals 
 IPTG and the antibiotics were purchased from Roth (Karl-
sruhe, Germany), octopamine, serotonin, and EPA from Sigma-
Aldrich (St. Louis, MO), and AA, eicosatetraynoic acid (ETYA), 
and all used eicosanoids from Cayman Chemicals (Ann Arbor, 
MI). Both quantity and purity of prepared eicosanoid stock solu-
tions were confi rmed by LC/MS/MS measurements (data not 
shown). The compound used as 17,18-EEQ agonist was synthe-
sized as described previously ( 21 ). To prevent autoxidation, all 
stock solutions, except for neurohormones, were prepared in an 
oxygen evacuated nitrogen chamber. DMSO, purchased from 
Sigma-Aldrich, was used as solvent; only neurohormones were 
dissolved in distilled water. 
 Preparation of assay plates and treatment 
 For long-term incubation, PUFA stocks were mixed with living 
OP50 bacteria and seeded on NGM plates at fi nal concentration 
of 80   M in the bacterial lawn, a concentration following the 
work of Watts et al. ( 10 ). Plates were dried in the dark. Worms 
from a mixed culture were chunked to assay plates to ensure that 
next generation was fed their whole life with dietary PUFA. Then, 
synchronized L1 progeny was incubated for 3 days prior use in 
the pumping assay. Synchronization was achieved by rinsing 
worms from NGM plates with M9 buffer, fi ltering through a 10   m 
gauze membrane retaining all but fi rst-stage juveniles, and incu-
bating them for a further 3 days on fresh NGM/OP50 agar plates. 
Control experiments were included by mixing only solvent, 0.3% 
(v/v) DMSO, with the bacteria. All chemicals used for short-term 
incubation were spread onto the NGM plates together with either 
UV-killed OP50 or HT115 (RNAi) bacteria. Octopamine was 
added to a fi nal concentration of 50 mM ( 17 ). The fi nal concen-
tration for eicosanoid (and EPA) treatment was 10   M. 
 To test the impact of octopamine on pumping in the presence 
of food, about 4 × 8 synchronized young adults were set on sepa-
rated small bacterial lawns for about 10 min to let them adapt. 
For the corresponding control, bacteria without supplementa-
tion were applied. In the eicosanoid assay, the same procedure 
was carried out except that the incubation time was 40 min. In 
this case, DMSO containing plates served as vehicle control. The 
different incubation times of neurohormone and eicosanoid as-
says required, in the case of a combined experiment, two sepa-
rate assay plates. Here, worms were set fi rst on an eicosanoid 
containing plate for 30 min, then picked to a neurohormone and 
eicosanoid containing plate and stayed for further 10 min. 
 For testing the impact of serotonin in the absence of food, 
about 4 × 8 synchronized young adults were set on a M9-agar 
plate, washed two times with small M9 drops, repicked to a sec-
ond M9-agar plate and incubated for 80 min. This strict proce-
dure prevented a notable carryover of bacteria and let worms in 
fact starve, clearly indicated by a sharp drop of pumping fre-
quency in the course of incubation time. Finally, worms were 
transferred to agar pads supplemented with 2 mM serotonin ( 22 ) 
for about 10 min to let them adapt. In the eicosanoid assay, the 
procedure was altered in the following way. After deprivation of 
food for 50 min, a small drop of M9 buffer mixed with 17,18-EEQ 
was dropped on an unseeded NGM plate. Then, the starved 
worms were picked into this drop and incubated for 40 min; the 
worms were not able to leave. To prevent evaporation, M9-infi ltrated 
fi lter paper was paved inside the lid and covered up. For the 
or  fat-3 (  -6 fatty acid desaturase) cause C20-PUFA defi ciency 
and lead to defi cits in movement, defecation cycle, pharyn-
geal pumping activity, basal innate immunity, and growth 
( 10 ). Almost all of these impairments are rather functional 
than developmental and can be rescued by feeding the 
mutant worms with AA and/or EPA ( 8, 11–13 ). 
 Searching for potential roles of CYP eicosanoids in  C. 
elegans , we found that the  cyp-33E2 gene is expressed in 
pharyngeal marginal cells. Gene silencing or pharmaco-
logical CYP inhibition reduced pharyngeal pumping fre-
quencies ( 7 ). This phenotype is shared by  fat-2 and  fat-3 
mutants, supporting the hypothesis that AA- and/or EPA-
derived CYP eicosanoids modulate pharyngeal activity. 
The pharynx is a rhythmically active pump that sucks, fi l-
ters, and grinds nutrients (bacteria) and passes them to 
the intestine of  C. elegans ( 14 ). The pharynx of nematodes 
appears related to the vertebrate heart: both organs move 
material along their lumens using binucleate cells and rely 
on similar electrical circuitry, and their geneses depend 
on related transcription factors ( 15 ). Pharyngeal pumping 
is controlled by endogenous and environmental cues and 
requires muscle-neuron interactions ( 16 ), whereby neuro-
hormones, such as serotonin (stimulatory effect) or octo-
pamine (inhibitory effect), play a major role ( 17–19 ). 
 Based on these fi ndings, we hypothesized that CYP eico-
sanoids may function as second messengers of neurohor-
mones regulating the feeding behavior of  C. elegans . We 
tested the effects of 17,18-EEQ and 20-HETE on pharyn-
geal pumping frequencies and the uptake of fl uorescent 
beads in both wild-type and C20-PUFA-defi cient strains 
and analyzed the effects of serotonin and octopamine on 
CYP eicosanoid de novo synthesis. 
 MATERIALS AND METHODS 
 Strains and cultivation 
 The  C. elegans wild-type strain used in this study was Bristol N2. 
Mutant strains are BX24,  fat-1(wa9) ; BX26,  fat-2(wa17) ; BX30,  fat-
3(wa22) ; MJ69,  emb-8(hc69) ; and VC40814,  cyp-29A3(gk827495) . 
All strains were provided by the Caenorhabditis Genetics Center. 
The million mutation project-derived VC40814 was outcrossed to 
wild-type fi ve times before analysis. Selection of  cyp-29A3 geno-
type took advantage of a missing  Mst I restriction site in the mu-
tant allele background. 
 Well-fed animals were maintained on nematode growth media 
(NGM) plates seeded with  Escherichia coli (Migula 1895) OP50 as 
food source and incubated at 20°C except  emb-8(hc69) , which was 
maintained at 15°C and shifted to restrictive 25°C during the assay; 
for details see ( 6 ). Only hermaphrodite individuals were assayed 
in all experiments. Unless otherwise stated, bacteria for pumping 
experiments were UV-killed by 1 h exposure to 5.6 mw/cm 2 UV-light 
on a transilluminator (Fluo-Link FL-20-M; Bachofer, Reutlingen, 
Germany). UV treatment was approved as effective when no  E. coli 
cells were able to grow after spreading bacterial suspension onto 
an lysogeny broth agar plate and incubated overnight at 37°C. 
 RNA interference by feeding 
 The RNA interference (RNAi) by feeding assay ( 20 ) was 
performed on NGM agar plates supplemented with additional 
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In the case of treatment with octopamine, harvested adult worms 
were immediately set on freshly prepared NGM plates containing 
50 mM octopamine in the bacterial lawn of  E. coli OP50. In the 
case of serotonin treatment, freshly prepared plates contained 
only 2 mM serotonin in the agar, but no bacteria. The corre-
sponding controls without octopamine or serotonin were han-
dled in the same way. The incubation time of this bulk culture 
was 15 min; afterward, the harvest was performed as described 
above. The CYP eicosanoid and fatty acid profi les of the har-
vested worms were determined using LC/MS/MS as described 
previously ( 6 ). To differentiate between esterifi ed and free CYP 
eicosanoids, the homogenates were extracted with or without 
prior alkaline hydrolysis. 
 Statistical analyses 
 Pumping assay and eicosanoid pattern data sets were analyzed 
by  t -test or one-way ANOVA to test for signifi cant differences be-
tween treatments followed by the Bonferroni test to identify 
treatments that were signifi cantly different from the control. All 
statistical tests were performed using Sigma Stat 3.5 (Systat Soft-
ware Inc., San Jose, CA). 
 RESULTS 
 Effect of genetic modifi cations reducing pharyngeal 
activity on the endogenous CYP-eicosanoid profi le 
 In a fi rst set of experiments, we compared the endoge-
nous CYP-eicosanoid profi le of wild-type nematodes with 
that of mutant strains displaying impairments in pharyn-
geal pumping activity ( Fig. 1 ).  For achieving various degrees 
of LC-PUFA/CYP-eicosanoid depletion, we took advan-
tage of the well-characterized pathway of LC-PUFA synthe-
sis in  C. elegans ( 8 ) ( Fig. 1A ). The  fat-1(wa9) mutant strain 
was used to analyze the effect of selectively depleting n-3 
PUFAs including EPA, whereas  fat-2(wa17) and  fat-3(wa22) 
served as strains defi cient in both EPA and AA (see supple-
mentary Table 1 for the detailed fatty acid profi les of the 
different strains). Moreover, we included the  emb-8(hc69) 
strain that expresses a temperature-sensitive CPR and, 
thus, allows the conditional knockdown of all CYP mono-
oxygenase activities in  C. elegans . All strains were viable un-
der laboratory conditions. The worms were fed with  E. coli 
OP50, a bacterium that mainly contains palmitic (16:0), 
palmitoleic (16:1 n-7), and vaccenic (18:1 n-7) acid, but 
not oleic acid (18:1 n-9) or PUFAs ( 23, 24 ). 
 The eicosanoid pattern of N2 wild-type worms revealed 
that EPA, the most abundant LC-PUFA in  C. elegans , was 
the preferred substrate for CYP-mediated eicosanoid pro-
duction. Counting all hydroxy- and epoxy-metabolites as 
well as the corresponding diols, the total content of EPA-
derived metabolites was more than 10-fold higher com-
pared with their AA-derived counterparts ( Fig. 1B ). 
Among the individual metabolites, 17,18-EEQ and its hy-
drolysis product 17,18-DHEQ were clearly predominant 
(supplementary Table 2). At the restrictive temperature, 
the thermosensitive  emb-8(hc69) strain showed a marked 
decrease in the content of all EPA- and AA-derived CYP 
eicosanoids ( Fig. 1B and supplementary Table 2). These 
data are in line with the notion that shifting the worms to 
the restrictive temperature (25°C) resulted in cessation of 
serotonin/17,18-EEQ combined experiment, again two separate 
assay plates were included and carried out as mentioned above 
for the octopamine assay. For the corresponding control, plates 
without supplementation were applied. 
 Pharyngeal pumping assay 
 Because the pumping rate of young adult wild-type worms is too 
fast to count correctly in real time, individual videos for 1 min at 
×500 magnifi cations were recorded using a VHX-600 digital micro-
scope (Keyence Corporation, Osaka, Japan). At least eight animals 
were tested per each trial; all experiments were performed at least 
in triplicate. Each individual pump was very carefully counted by 
playing back each individual video at half to fi fth speed according 
to the pumping frequency of different strains and conditions. 
 Feeding assay 
 We used FluoSphere ® carboxylate modified microspheres 
(red fl uorescent; 0.5   m) from Life Technologies (Carlsbad, CA) 
in this assay. The original microspheres were diluted 1:50 in M9 
buffer. For well-fed conditions, 25   l of particle suspension was 
mixed with 175 µl of OP50 bacterial suspension [optical density 
(OD) 600 = 4.5] containing chemicals at the concentrations as de-
scribed before and pipetted to a 6 cm NGM agar plate. These 
exposure plates were dried in the dark. For beads accumulation 
in the presence of food, 50 age-synchronized young adult her-
maphrodites were picked onto a 20-HETE containing or control 
plate for 30 min preexposure. Then, nematodes were transferred 
to an exposure plate to allow them to ingest of microspheres for 
10 min. After that worms were anesthetized using 50 µl of sodium 
azide (1 M). For testing octopamine, worms were picked directly 
to exposure plates containing only 50 mM octopamine and incu-
bated for 10 min. For combined exposure, 20-HETE preincu-
bated worms were transferred to an exposure plate containing 
both octopamine and 20-HETE. For starved condition, worms 
were cultivated in the absence of food prior the test as described 
above: for 80 min in the case of subsequent serotonin exposure 
and for 50 min in the case of individual 17,18-EEQ and subse-
quent joint exposure. Besides that M9 buffer was used instead of 
bacterial suspension, all other steps were identical as in the case 
of the well-fed condition. 
 Before measuring the density of fl uorescence, 35 worms were 
picked on an unseeded part of the used NGM plate to wash them 
several times with M9 buffer. Then, 5 × 7 worms were transferred 
to a 96-well V-bottom plate fi lled with 100 µl of pure ethanol and 
measured by using an Infi nite F200 Pro (Tecan, Männedorf, 
Switzerland) fl uorescence reader (560 nm/612 nm) for three 
times with a 5 min interval between each. The usage of ethanol 
prevented sticking of worms on the sidewall of wells and ensured 
the complete localization on the bottom of plates. The entire test 
was repeated two times. Microscopic images were acquired with 
an Eclipse E200 from Nikon (Chiyoda, Tokyo, Japan) coupled to 
a VHX-600 digital camera (Keyence Corporation). 
 Analysis of endogenous fatty acid and eicosanoid pattern 
 Synchronized 3-day-old adult worms were carefully washed off 
from NGM agar plates with a few milliliters of M9 buffer by 
slightly canting the plates back and forth. This procedure re-
moved almost all adult worms but hardly any laid eggs from the 
plate. All steps were performed in the cold at 4°C. Already 
hatched small larvae were separated by fi ltering through a 10   m 
gauze membrane. The resulting worm fi lter cake with the adult 
worms was rinsed from the membrane and washed two times 
with M9 buffer to remove adhering bacteria. Then, the worms 
(  50 mg fresh weight) were transferred to a 1.5 ml reaction tube 
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 Fig. 1. Endogenous CYP-eicosanoid profi les and pumping frequencies in different  C. elegans strains. A: 
Pathway of LC-PUFA and eicosanoid synthesis in  C. elegans . AA (20:4n-6); ALA (18:3n-3); DGLA, dihomo-  -
linolenic acid (20:3n-6); EPA (20:5n-3); GLA,   -linolenic acid; LA (18:2n-6); OA, oleic acid (C18:1n-9); 
O3AA, n-3 arachidonic acid; SDA, stearidonic acid (18:4n-3). Outside the gray box, CYP-dependent eico-
sanoid synthesis and the soluble epoxide hydrolase (sEH) (CEEH-1 and -2)-mediated hydrolysis of epoxides 
( 40 ) are shown. DHEQ, dihydroxyeicosaquatraenoic acid; DHET, dihydroxyeicosatrienoic acid; EET, ep-
oxyeicosatrienoic acid; HEPE, hydroxyeicosapentaenoic acid. B: Cultured wild-type and designated mutant 
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EPA, AA, and ETYA, a nonmetabolizable AA analog, for 
their capacities to rescue the impaired pharyngeal pump-
ing activity of the  fat-3(wa22) and  fat-2(wa17) mutant 
strains. As expected from previous studies ( 10, 11 ), long-
term feeding with either EPA or AA signifi cantly improved 
the impaired pharyngeal activity of both the mutant strains 
( Fig. 2B , C ).  However, C20-PUFA supplementation did 
not further increase the high pharyngeal pumping fre-
quencies of wild-type worms that produce AA and EPA en-
dogenously ( Fig. 2A ). In contrast to AA and EPA, ETYA 
was unable to rescue the impaired pharyngeal pumping 
activity of both  fat-3(wa22) and  fat-2(wa17) mutant strains 
indicating that AA- and EPA-derived metabolites, rather 
than the parental C20-PUFAs, were required ( Fig. 2B, C ). 
In order to distinguish between developmental or acute 
requirements for C20-PUFAs in unimpaired pharyngeal 
pumping, we provided EPA to  fat-3(wa22) and  fat-2(wa17) 
mutant strains at the last larval stage (L4), after most tis-
sue development and differentiation has occurred. This 
24 h of EPA supplementation was found suffi cient to sig-
nifi cantly rescue both  fat-3(wa22) ( Fig. 2B ) and  fat-2(wa17) 
( Fig. 2C ) worms from defi cits in pumping activity. Never-
theless, whereas in the case of  fat-3(wa22) this rescue was in 
same range as in the long-term feeding,  fat-2(wa17) worms, 
supplemented with EPA only 24 h post L4, pumped still 
signifi cantly lower when compared with long-term feed 
worms; its rescue level was only half as much as when EPA 
was present during the complete development ( Fig. 2C ). 
 Searching for the identity of the bioactive metabolites, 
we next tested several of the EPA- and AA-derived CYP 
eicosanoids for their capacity to modulate pharyngeal ac-
tivities in wild-type and mutant strains. Based on prelimi-
nary experiments with the major EPA-derived metabolite 
(17,18-EEQ), we selected the lowest effective concentra-
tion of 10 µM in combination with a 40 min preincubation 
time for comparing the effects of various compounds on 
pumping frequencies (supplementary Fig. 1). Please note 
that all concentration specifi cations of used compounds 
refer to exogenously administered media or buffers and 
do not refl ect incorporated or internal amounts, con-
sidered as effective in lower concentrations. Under these 
short-term exposure conditions ( Fig. 3 ),  EPA had no ef-
fect, contrary to the rescue experiments described above, 
where we used long-term feeding for several days with 
80 µM C20-PUFAs. However, short-term treatment with 
17,18-EEQ accelerated pharyngeal pumping even above 
basal frequency in the wild type ( Fig. 3A ) and rescued the 
 fat-3(wa22) mutant strain to the same extent as long-term 
EPA-feeding [compare  Fig. 3B and  Fig. 2B , as well as sup-
plementary Videos 2 and 3, presenting an untreated  fat-
3(wa22) with 207 pumps/min and a 17,18-EEQ-treated 
CYP eicosanoid de novo synthesis and progressive degra-
dation of those metabolites that were produced during the 
prior period at permissive temperature (15°C). Each of 
the desaturase mutants analyzed exhibited signifi cant al-
terations in CYP-eicosanoid formation ( Fig. 1B and sup-
plementary Table 2). These alterations clearly refl ected 
the different availabilities of LC-PUFAs in the mutant 
strains compared with the wild-type (for the details, see 
supplementary Table 1). The  fat-2(wa17) and  fat-3(wa22) 
strains almost completely lacked any of the AA- or EPA-
derived CYP eicosanoids. The  fat-1(wa9) strain was almost 
free of EPA-derived metabolites but produced largely in-
creased amounts of AA-derived CYP eicosanoids compared 
with the wild type. 
 Fig. 1C compares the pharyngeal activities of the strains 
characterized above regarding their fatty acid and CYP-
eicosanoid profi les. The pumping frequencies were deter-
mined using young adult, well-fed worms. Under these 
conditions, the pharynx of N2 wild-type worms regularly 
pumped with a frequency of 285.7 ± 15.5 (mean ± SD) 
contractions/min. This value is located at the upper end 
of the previously published range, for instance 200–300 
pumps per minute for adults ( 25 ) as well as 250–300 ( 26 ) 
and 266.1 ± 3 ( 27 ) for young adults, in each case, mea-
sured in the presence of food. It is important to note that 
this work determined pumping frequency by playing back 
previously recorded individual videos at reduced speed 
and counting each individual pump carefully. Usually, phar-
ynx pumping rates of adult worms were scored by eye under 
a microscope, a method that can hardly be controlled, 
making them more prone to errors. We added four rep-
resentative videos as supplementary information. The 
1-minute fi lm of supplementary Video 1 shows an N2 wild-
type worm pumping 290 times. 
 The  fat-2(wa17) and  fat-3(wa22) mutant strains displayed 
largely reduced pumping frequencies. Actually, these 
AA- and EPA-defi cient worms pumped with about 110 [ fat-
2(wa17) ] and 80 [ fat-3(wa22) ] contractions/min less than 
the N2 strain, corresponding to about 60% and 70%, re-
spectively, of wild-type activity. Supplementary Video 2 
shows a  fat-3(wa22) worm with 207 pumps per minute. In 
contrast,  fat-1(wa9) worms showed pumping frequencies 
almost identical to the wild type, indicating that n-3 PUFA-
defi ciency alone is not suffi cient to impair pharyngeal ac-
tivity. Inactivation of EMB-8 resulted in a moderate, but 
still signifi cant decrease to   90% of wild-type activity. 
 Rescue of pharyngeal activity impairments by C20-PUFAs 
and CYP eicosanoids 
 To further analyze the link between LC-PUFAs, CYP 
eicosanoids, and the observed phenotype, we compared 
bars show the total amounts of AA- or EPA-derived metabolites and represent the sum of the corresponding 
n- and (n-1)-hydroxylase products as well as the sum of epoxy- and dihydroxy-metabolites. Results are means + 
SD from three independent experiments performed for each strain. For the detailed metabolite profi les, see 
supplementary Table 2. C: Eicosanoid defi ciencies were associated with pumping frequency impairments. All 
nematodes were monitored on the fi rst day of adulthood. Shown are the contractions per minute (three 
trials with n = 8–12 per trial); error bars represent SD; comparisons were made using one-way ANOVA. **  P < 
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due to CPR inactivation ( Fig. 3D ) or RNAi-mediated inhi-
bition of  cyp-29A3/cyp-33E2 expression ( Fig. 3F ). In the 
case of  fat-2(wa17) ( Fig. 3C ), only the more effective con-
centration of 20 µM (compare supplementary Fig. 1) was 
suffi cient to signifi cantly alter the pharyngeal pumping 
activity, indicating again developmental defi cits in this 
strain not fully compensable by dietary supplementation. 
Notably, a synthetic 17,18-EEQ analog was as effective as 
the natural 17,18-EEQ in elevating the pumping frequen-
cies ( Fig. 3F, G ). Further confi rming the high specifi city of 
the 17,18-EEQ effect, neither its hydrolysis product, the 
corresponding diol (17,18-DHEQ), nor the AA-derived 
metabolite 14,15- EET did increase the pumping frequen-
cies ( Fig. 3F, G ). Only the AA-metabolite 11,12-EET was 
able to mirror the 17,18-EEQ effect ( Fig. 3F, G ). 
 The AA-derived 20-HETE showed opposite properties 
compared with 17,18-EEQ. This hydroxy-metabolite sig-
nifi cantly decreased pharyngeal pumping frequencies in 
the wild as well as in all genetically modifi ed strains tested 
( Fig. 3A–E ). The 1-minute fi lm of supplementary Video 4 
shows a 20-HETE treated N2 wild-type worm pumping 
257 times/min. In wild-type worms, both its regioisomer 
19-HETE and the EPA-derived analog 20-HEPE were not 
able to reduce pumping frequency ( Fig. 3A ). Moreover, the 
joint treatment of worms with both 20-HETE and 19-HETE 
only marginally reduced the 20-HETE activity ( Fig. 3A ). 
 Comparison of CYP-eicosanoid and neurohormone 
effects on pumping frequency 
 Whereas effects of CYP eicosanoids on pharyngeal activ-
ity of  C. elegans were never described before, it has been 
well established that the pumping frequency is regulated 
by neurohormones, such as the biogenic amines serotonin 
and octopamine ( 17–19 ). Accordingly, the following ex-
periments were designed to gain insight into potential 
links between neurohormone and CYP-eicosanoid actions. 
A fi rst series of experiments was performed using worms 
completely deprived of food for 90 min, taking into ac-
count that serotonin exerts its stimulatory effect most 
strongly after starvation and mimics the worm’s response 
to refeeding. During the starvation period, the pharyngeal 
pumping frequency of the wild-type strain declined from 
about 285.7 ± 15.5 to 82.2 ± 11.0 contractions/min and 
became highly responsive to exogenously added sero-
tonin. In contrast, we used well-fed worms for studying 
the effect of octopamine because this neurohormone is 
thought to reduce pharyngeal pumping under conditions 
of satiation. 
 As shown in  Fig. 4A , starved wild-type worms responded 
to exogenously administered serotonin with a very strong 
acceleration of pharyngeal pumping.  17,18-EEQ mim-
icked the effect of serotonin and was actually as effective as 
the neuromodulator. The remarkable capacity of 17,18-
EEQ to stimulate the pumping frequency of starved worms 
was detectable not only in the wild type, but also in the 
 emb-8(hc69) ,  fat-3(wa22) , and  fat-2(wa17) mutant strains, re-
spectively. An even higher stimulating effect was achieved 
by combined administration of serotonin and 17,18-EEQ, 
signifi cant in the case of  emb-8(hc69) and  fat-2(wa17) . 
 fat-3(wa22) worm pumping with 237 pumps/min, respec-
tively]. Moreover, 17,18-EEQ signifi cantly increased the 
pumping frequencies in those strains that were designed 
to have limited capacities for CYP-eicosanoid formation 
 Fig. 2. Rescue of  fat-3(wa22) mutant worms from pumping im-
pairment. Long-term feeding with EPA and AA, but not ETYA, a 
nonmetabolizable AA analog, rescued the impaired pumping of 
the  fat-3(wa22) (B) and  fat-2(wa17) (C) strains but did not change 
pharyngeal activity in the wild type (A). Shown are the contractions 
per minute (three trials with n = at least 8 per trial); error bars 
represent SD; comparisons were made using one-way ANOVA. 
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 Fig. 3. Contrasting effects of different CYP eicosanoids on pumping activity. A – E: 17,18-EEQ increased 
whereas 20-HETE decreased the pumping frequency in the wild type and in the genetically modifi ed strains 
 fat-3(wa22) ,  fat-2(wa17), emb-8(hc69) , and  cyp-29A3/cyp-33E2 (RNAi). F, G: The 17,18-EEQ effect was mimicked 
by a synthetic agonist and 11,12-EET but not by 17,18-DHEQ or 14,15-EET. Shown are in each case the con-
tractions per minute (three trials with n = at least 8 per trial); error bars represent SD; comparisons were 
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 Fig. 4. Comparison of CYP-eicosanoid- and neurohormone-induced effects on pharyngeal pumping fre-
quencies. A: 17,18-EEQ mimicked the strong stimulating effect of serotonin when applied to the starved wild 
type or  fat-3(wa22) ,  fat-2(wa17) , and  emb-8(hc69) mutant strains. B: Exogenous administration of octopamine 
as well as 20-HETE downregulated the pumping frequency in well-fed wild-type worms. The  fat-2(wa17) and 
 emb-8(hc69) mutant worms were partially octopamine resistant but responded to 20-HETE with decreased 
pumping activity. C: CYP-29A3-defi cient strains did not respond to 50 mM octopamine but still to 20-HETE. 
Shown are the contractions per minute (three trials with n = at least 8 per trial); error bars represent SD; 
comparisons were made using one-way ANOVA. *  P < 0.05, **  P < 0.01, ***  P < 0.001; plasmid control: empty 
RNAi feeding control. O./Octop., octopamine; S., serotonin; 20-H., 20-HETE. Unless otherwise specifi ed, 
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Selective downregulation of CYP-33E2 produced a differ-
ent phenotype. RNAi-mediated silencing of  cyp-33E2 alone 
caused already a signifi cant deceleration of pumping fre-
quency in well-fed worms. Treatment with octopamine 
trended to result in a further decrease of pumping activity; 
however, this effect was only signifi cant compared with the 
RNAi plasmid control ( Fig. 4C ). 
 Effect of neurohormones on endogenous CYP-eicosanoid 
formation 
 Next, we analyzed acute effects of serotonin and octopa-
mine on the formation of CYP eicosanoids in  C. elegans 
( Fig. 5 ).  Again, we used starved and well-fed worms for 
testing the responses to serotonin and octopamine, re-
spectively. Without any neurohormone treatment, starved 
and well-fed wild-type worms showed clear differences in 
the endogenous levels of free CYP eicosanoids (compare 
the left panels in  Fig. 5A, C ). In particular, the 17,18-EEQ 
levels were signifi cantly (almost 3-fold) lower in starved 
than well-fed worms. 
 Serotonin treatment for 15 min resulted in a signifi -
cant, almost 2-fold, increase of free 17,18-EEQ levels in 
starved wild-type worms ( Fig. 5A ). Simultaneously, serotonin 
 As shown in  Fig. 4B , octopamine exerted its expected 
effects by moderately reducing the pumping frequency of 
well-fed wild-type and  fat-3(wa22) worms. The  emb-8(hc69) 
strain, cultivated at restrictive temperature, as well as the 
PUFA-defi cient  fat-2 strain, failed to respond to octopa-
mine (50 mM). Raising the octopamine concentration to 
80 mM overcame this ineffectiveness to some extent, sig-
nifi cantly in the case of  fat-2(wa17) . 20-HETE was clearly 
effective when added on top of octopamine, suggesting 
that lack of endogenous 20-HETE formation might be 
responsible for the inability of the  emb-8(hc69) and  fat-
2(wa17) strains to response to 50 mM octopamine ( Fig. 4B ). 
Based on this notion, we next tested the potential involve-
ment of CYP-29A3 and/or CYP-33E2 in providing 20-HETE 
for the octopamine response ( Fig. 4C ). RNAi-mediated si-
lencing of both genes indeed abolished the response of 
wild-type worms to octopamine (50 mM). Similarly, the 
 cyp-29A3(gk827495) strain that carries a loss-of-function 
mutation in the  cyp-29A3 gene was resistant against octopa-
mine. However, the  cyp-29A3(gk827495) strain still clearly 
responded to exogenous 20-HETE ( Fig. 4C ), resembling 
the results obtained with  emb-8(hc69) and  fat-2(wa17) , the 
two other octopamine-resistant strains (compare  Fig. 4B ). 
 Fig. 5. Effect of neurohormones on CYP-eicosanoid formation. A: The addition of serotonin to starved 
wild-type worms caused increased endogenous levels of free 17,18-EEQ but not of hydroxy-metabolites. B: 
Octopamine treatment of well-fed wild-type worms selectively induced the formation of free AA- and EPA-
derived hydroxy metabolites including 19-HETE, 20-HETE and 19-HEPE, and 20-HEPE. C, D: Starved as well 
as well-fed  emb-8(hc69) worms incubated at the restrictive temperature featured strongly reduced CYP-eico-
sanoid levels compared with the corresponding wild-type controls. Moreover, these CPR-defi cient worms 
neither responded to serotonin nor to octopamine with changes in CYP-eicosanoid formation. Results are 
means + SD from three independent experiments performed for each strain. Note that in the case of divided 
boxes the upper part presents the 19-hydroxy metabolite and the lower part the 20-hydroxy metabolite. 
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 Effects of CYP eicosanoids and neurohormones on 
food uptake 
 Finally, we analyzed the effi ciency of food uptake by 
quantifying the incorporation of fl uorescent beads ( Fig. 6 ). 
 This assay provides information not only on pumping, 
typically counted as cycle of contraction and relaxation of 
the terminal bulb, but also on peristalsis as an essential 
second feeding motion generating a moving wave of con-
traction of the muscles of the posterior isthmus that car-
ries food from the corpus to the terminal bulb ( 25 ). 
Several studies indicated that the uptake of particles was 
indeed related to pharyngeal pumping rate and responded 
to changes in nutritional status ( 22, 28–30 ). Nevertheless, 
terminal bulb contractions, which are not timed properly 
with those in the corpus, can prevent transport of food (or 
beads) into the intestine. We used this assay also to dem-
onstrate concentration- and time-dependent effects of 
17,18-EEQ treatment on pharyngeal activity (see supple-
mentary Fig. 1). 
 The feeding assay was performed both with well-fed 
worms in the presence of food and starved worms, exclu-
sively incubated with beads. Starved worms incorporated 
signifi cantly more beads when treated with serotonin; 
induced a decline of free hydroxy-metabolites that was sig-
nifi cant for 19-HEPE but not for 19-/20-HETE ( Fig. 5A ). 
Compared with wild type, the CPR-defi cient  emb-8(hc69) 
strain displayed largely reduced levels of free CYP eico-
sanoids already under basal conditions and was unable to 
increase 17,18-EEQ formation in response to serotonin 
( Fig. 5C ). 
 In contrast to serotonin, octopamine primarily induced 
the formation of hydroxy-metabolites ( Fig. 5B ). Actually, 
the free levels of 19-/20-HETE as well as of 19-/20-HEPE 
were almost doubled after treating well-fed wild-type 
worms for 15 min with octopamine. However, octopamine 
had no signifi cant effect on 17,18-EEQ that only slightly 
increased its high level as characteristic for well-fed worms. 
Compared with the wild type, the  emb-8(hc69) strain showed 
signifi cantly lower basal levels of 19-/20-HETE as well as of 
19-/20-HEPE and 17,18-EEQ ( Fig. 5D ). Importantly, the 
well-fed CPR-defi cient worms also lost the ability to in-
crease hydroxy-metabolite formation in response to octo-
pamine, indicating that de novo CYP-eicosanoid synthesis 
was required for the octopamine-induced changes in the 
free hydroxy-metabolite levels observed in the wild-type 
strain (compare  Fig. 5B, D ). 
 Fig. 6. Contrasting effects of 17,18-EEQ and 20-HETE on the food uptake. Shown is the relative effect of 
neurohormones and CYP eicosanoids on the accumulation of 0.5 µm fl uorescent beads. The accumulation 
was assayed with starved worms (A), incubated in the absence of  E. coli cells, and well-fed worms (B), incu-
bated in the presence of  E. coli cells. Representative bright fi eld and fl uorescence images, arranged as pairs 
one below the other, show starved (C) and well-fed (D) adult worms allowed to uptake the red fl uorescent 
beads for 10 min at 20°C. The photographs were taken at ×100 magnifi cation, using an exposure time of 
1/30 s for the fl uorescence images in C and of 1/5 s in D; white bars correspond to 100 µm. Data are means + 
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(compare supplementary Table 1) as well as derived me-
tabolites can partially compensate the absence of C20-
PUFA. In contrast, this kind of rescue was incomplete in 
 fat-2(wa17) worms, producing no PUFA at all. These data 
indicate that there are at least two separable requirements 
for EPA (and probably other PUFAs) in normal adult 
pumping behavior including both acute and developmen-
tal requirements. 
 Searching for the identity of the bioactive metabolites, 
we fi rst tested 17,18-EEQ, the major CYP eicosanoid en-
dogenously produced in wild-type worms. Indeed, 17,18-
EEQ was alone suffi cient to rescue impaired pharyngeal 
pumping in the LC-PUFA- and in the CPR- or CYP-33E2-
defi cient strains. Moreover, we found that the formation 
and action of 17,18-EEQ was associated with the typical 
behavioral response of  C. elegans to refeeding. Deprivation 
of food (bacteria) resulted in a strong deceleration of pha-
ryngeal pumping frequencies and simultaneously in a re-
duction of free 17,18-EEQ levels. After starvation, the 
worms responded to exogenously supplied 17,18-EEQ 
with a marked acceleration of pharyngeal pumping and 
concomitantly with increased food uptake capacity as visu-
alized by enhanced incorporation of fl uorescent-labeled 
beads. However, 17,18-EEQ-treatment exerted a slight stim-
ulating effect already in well-fed worms, suggesting that 
the endogenous 17,18-EEQ levels did not fully saturate the 
stimulating mechanisms even in the presence of abun-
dant food. It might be argued that in isolated mamma-
lian cells an even lower concentration of, e.g., 17-18-EEQ 
was found effective, as 1 µM, with respect to Ristocetin-
induced thrombocyte aggregation ( 36 ), or even 30 nM, 
which caused antiarrhythmic effects in isolated neonatal 
rat cardiomyocytes ( 37 ). However,  C. elegans as living or-
ganism cannot be considered as comparably accessible as 
vulnerable segregated cells. This applies even more in the 
light of an encapsulated pharynx, isolated from the rest of 
the worm by a specialized basal lamina. Moreover, recent 
investigations revealed that the more economic approach 
of spotting compounds on the agar surface achieved lower 
absorption effi ciency in worms when compared with 
other drug delivering methods, as pouring compounds 
together with agar ( 38 ). In the case of the spot method, the 
solution will immerse into the NGM agar, which reduces 
the availability. 
 A reaction potentially limiting 17,18-EEQ levels consists 
in the hydrolysis of this epoxy-metabolite to the corre-
sponding vicinal diol (17,18-DHEQ). Supporting this no-
tion, our LC/MS/MS data showed, besides 17,18-EEQ, 
also high 17,18-DHEQ levels in the wild-type worms. Fur-
thermore, we found that 17,18-DHEQ did not share the 
capacity of 17,18-EEQ to stimulate pharyngeal activity. In 
mammals, hydrolysis of LC-PUFA-derived epoxy-metabolites 
is catalyzed by sEH and frequently also results in a loss of 
their biological activities ( 39 ). Candidates for mediating 
17,18-EEQ inactivation in  C. elegans are  ceeh-1 and  ceeh-2 , 
two genes encoding enzymes orthologous to mammalian 
sEH ( 40 ). Our study also indicates that 17,18-EEQ, if not 
available, can be replaced by other metabolites, as 11,12-
EET. Strong evidence for this notion also comes from the 
17,18-EEQ successfully mimicked this effect and the com-
bined exposure of both agents was slightly more effective than 
serotonin or 17,18-EEQ alone ( Fig. 6A ). Well-fed worms 
reduced the uptake of beads when treated with octopa-
mine, an effect that was also elicited by 20-HETE; a com-
bined treatment resulted in an additive effect ( Fig. 6B ). 
Representative microscopic images are shown in  Fig. 6C, 
D . The labeling is visible in the terminal bulb of the phar-
ynx and the whole intestinal lumen; the overall intensity of 
fl uorescence mirrored the contrasting effects of 17,18-
EEQ (excitatory) and 20-HETE (inhibitory), respectively. 
 DISCUSSION 
 The present study provides direct experimental evidence 
of a role for CYP eicosanoids in the regulation of pharyn-
geal pumping and food uptake in the nematode  C. elegans . 
In particular, we found that 17,18-EEQ contributed to resto-
ration of high pumping frequencies in LC-PUFA defi cient 
strains, whereas 20-HETE reduced pharyngeal activities 
and food uptake. Moreover, we show that the formation 
and action of 17,18-EEQ did closely mimic the stimula-
tory effect of the neurohormone serotonin. In contrast, 
20-HETE and related hydroxy-metabolites were possibly 
linked to the decelerating effect of octopamine. 
 Confi rming and extending previous results ( 8, 10, 11 ), 
we detected impaired pharyngeal activities in all mutant 
strains that were defi cient in the endogenous production 
of both EPA and AA. Consequently, these mutant strains 
also almost completely lacked EPA- and AA-derived me-
tabolites, raising the question whether the parental fatty 
acids or more directly the corresponding CYP eicosanoids 
were required for maintaining pharyngeal activities. The 
same question also applies to the other behavioral pheno-
types associated with C20-PUFA-defi ciency. As shown re-
cently, the touch sensation defect of  fat-3(wa22) can be 
rescued supplementing the worms during complete de-
velopment with EPA and AA, but also with ETYA, an AA-
analog ( 31 ). ETYA harbors triple instead of double bonds 
( 32 ) and has been used as a nonmetabolizable analog of 
AA and inhibitor of AA-derived eicosanoid formation ( 33–
35 ). These fi ndings suggested that C20-PUFAs modulate 
 C. elegans ’ touch sensation while being incorporated into 
membrane phospholipids and that CYP-eicosanoid forma-
tion is not required to maintain this phenotype ( 31 ). In 
clear contrast, we found that pharyngeal pumping fre-
quencies can be only rescued by EPA and AA, but not by 
ETYA. This outcome of the ETYA experiment, combined 
with our observation of reduced pumping activities in the 
CPR- and CYP-33E2-defi cient strains, clearly indicated that 
AA- and EPA-derived metabolites rather than the parental 
C20-PUFAs are required for maintaining high pharyngeal 
activities. The function of C20-PUFA in pharyngeal activity 
appears to be in fact independent of developmental roles 
of these PUFAs, as providing EPA for 24 h to  fat-3(wa22) 
post L4 stage was suffi cient for restoration of high pump-
ing frequency in young adults. It seems likely that in the 
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n-6 PUFA and derived CYP eicosanoids, is not suffi cient to 
lower its pumping frequency. 
 The interpretation of our results with 17,18-EEQ is sim-
ilarly complex. Our data show that 17,18-EEQ is involved 
in maintaining high pumping and food uptake rates in 
the presence of bacteria. Moreover, 17,18-EEQ was in-
creasingly produced in response to serotonin and elic-
ited, like this neuromodulator, the behavioral response of 
refeeding. However, 17,18-EEQ was obviously not essen-
tial for mediating the serotonin effect. Supporting this 
notion, we found that CPR-defi cient worms responded to 
serotonin with increased pumping frequencies, despite 
their inability for de novo 17,18-EEQ synthesis. Further-
more, pharyngeal pumping of  fat-2 mutant worms was se-
rotonin responsive, although this strain was completely 
devoid of any PUFAs and CYP eicosanoids. These results 
indicate that serotonin can exert its stimulatory effect 
both via 17,18-EEQ-dependent and independent path-
ways. Moreover, it appears possible that 17,18-EEQ is used 
as a second messenger primarily by other transmitters 
that act downstream (e.g., acetylcholine) or independent 
of serotonin. Mutants defective in the serotonin receptor 
SER-7 do not respond to serotonin, but still respond to 
bacterial food, suggesting that serotonin is indeed not the 
only transmitter relaying the physiological response of 
refeeding ( 47 ). 
 Various aspects of the hypothetical pathway remain to 
be clarifi ed. A fi rst question concerns the identity and cel-
lular localization of the CYP isoforms involved. CYP-29A3 
appears responsible for the formation of 20-HETE and 
other hydroxy-metabolites as indicated by the lack of 
clear octopamine response in the CYP-29A3 knockout 
strain. However, the expression site of CYP-29A3 remains 
to be defi ned considering that the pharyngeal machinery 
is constituted by various neuronal, marginal, and muscle 
cells. CYP-33E2 is the leading candidate for producing 
17,18-EEQ, based on the activity of the recombinant en-
zyme, its localization in pharyngeal marginal cells, and 
the reduced pharyngeal activities observed after downreg-
ulating CYP-33E2 expression ( 7 ). However, pharyngeal 
marginal cells also express CYP-13A12, a CYP enzyme that 
is involved in  C. elegans’ response to hypoxia/reoxygenation 
and presumably shares with CYP-33E2 the capacity of 
producing 17,18-EEQ ( 48 ). Another important open ques-
tion concerns the selective induction of 17,18-EEQ versus 
20-HETE formation, respectively. CYP enzymes require 
free fatty acids as substrates. This feature ensures cou-
pling of CYP-eicosanoid de novo synthesis to the action 
of extracellular signals that activate phospholipase A 2 
(PLA 2 ), which in turn release free C20-PUFAs from mem-
brane phospholipids ( 1, 49 ). Currently, it is unclear whether 
one of the serotonin or octopamine receptors may trig-
ger PLA 2 activation and which of the diverse PLA 2 
enzymes expressed in  C. elegans are involved. Finally, 
it may be presumed, but has to be directly shown, that 
pharyngeal muscle cells contain receptors selectively rec-
ognizing 17,18-EEQ or 20-HETE and in turn trigger sig-
naling pathways accelerating or decelerating pharyngeal 
pumping. 
fi nding that the EPA-defi cient  fat-1(wa9) strain did not 
show any impairment in pharyngeal pumping activity. 
This strain produced largely increased amounts of AA-
derived metabolites. 
 Contrary to the stimulating effect of 17,18-EEQ, 20-
HETE decreased pharyngeal activities when added to well-
fed worms. 20-HETE thus elicited a response otherwise 
indicating satiation. This effect was detectable not only in 
the wild type but also in all of the genetically modifi ed 
strains tested. The requirement of a doubled concentra-
tion of eicosanoids for being active also in  fat-2(wa17) gave 
further evidence that the complete absence of PUFAs in 
worm’s development resulted in impairments that inter-
fere with the restoration of high pumping frequencies. 
We selected 20-HETE as a representative of the various 
hydroxy-metabolites present in  C. elegans . An additional test-
ing of 19-HETE and 20-HEPE did not reduce the pumping 
speed of well-fed young wild-type adults, confi rming the 
high specifi city of the 20-HETE effect. However, we cannot 
exclude and will have to test in future experiments that 
the inhibitory effect of 20-HETE is shared by further AA- 
and EPA-derived hydroxy-metabolites such as specifi c ste-
reoisomers of HETE and HEPE. 
 We speculated that CYP eicosanoids are integrated as 
second messengers of neurohormones into the complex 
regulation of pharyngeal activity and food uptake in 
C. elegans . As reviewed by Avery and You ( 25 ), it has been 
well-established that pharyngeal muscle activities are co-
ordinated by the pharyngeal nervous system for allowing 
effi cient contractions and stimulation of fast pumping 
in response to food and slow pumping in response to star-
vation or satiation. In the absence of the pharyngeal ner-
vous system, a muscle-intrinsic pathway promotes only 
very slow pumping (26 pumps/min in the presence of 
food) ( 41 ). In the unaffected wild type, both serotonin 
and acetylcholine stimulate fast pumping, whereas gluta-
mate acts as an inhibitory neurotransmitter ( 17, 42, 43 ). 
Also octopamine reduces pharyngeal pumping when added 
to intact worms ( 17 ) or isolated pharynx preparation 
( 18 ). The cellular origins of this bioamine neurotransmit-
ter are ring interneurons C of the head region and go-
nadal sheath cells ( 44 ), known octopamine receptors, 
SER-3 and OCTR-1, are expressed in head neurons, too 
( 45, 46 ). 20-HETE not only mimicked the inhibitory ef-
fect of octopamine but was also increasingly produced 
in response to octopamine. Moreover, we found that the 
CPR- or CYP-29A3-defi cient strains failed to respond to 
the inhibitory neurotransmitter, but still responded to 
20-HETE. On the other hand, C20-PUFA-defi cient strains 
 fat-3(wa22) and  fat-2(wa17) were able to respond to octo-
pamine treatment with a drop in pumping frequency, 
but the latter only after increasing octopamine’s nominal 
concentration to 80 mM. Also the data of the fl uorescent 
beads uptake experiments with the wild type in the pres-
ence of octopamine and 20-HETE tend to argue for a 
rather independent (additive) action of both substances. 
Further work will be necessary to close this knowledge 
gap, e.g., the open question why a notably high 20-HETE 
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 From a more general perspective, the questions raised 
above similarly apply to the formation and action of CYP 
eicosanoids in mammalian systems. Resembling our fi nd-
ings on the opposite roles of 17,18-EEQ and 20-HETE in 
 C. elegans , EETs act as second messengers of vasodilatory 
hormones, whereas 20-HETE mediates vasoconstriction 
in the mammalian vasculature ( 50, 51 ). EETs were fi rst 
characterized as endothelium-dependent hyperpolarizing 
factors when analyzing the components mediating the 
vasorelaxing effects of acetylcholine and bradykinin ( 52 ). 
EET-generating CYP enzymes are primarily localized in 
endothelial cells and 20-HETE formation occurs predomi-
nantly in vascular smooth muscle cells. Partially explaining 
the opposite effects, EETs activate whereas 20-HETE in-
hibits large conductance Ca 2+ -activated potassium (BK) 
channels in vascular smooth muscle cells ( 50, 53 ). In  C. 
elegans , BK channels are involved in regulating muscle 
Ca 2+ -transients ( 54, 55 ) as well as neurotransmitter release 
at neuromuscular junction ( 56 ). 17,18-EEQ shares and, in 
several vascular beds, even largely exceeds the vasodilatory 
( 57 ) and BK channel activating effects of EETs ( 58 ). More-
over, 17,18-EEQ relaxes airway smooth muscle cells in the 
human lung ( 59 ) and potently modulates the contractility 
of cardiomyocytes ( 37 ). Interestingly, a synthetic com-
pound developed to mimic the effect of 17,18-EEQ on car-
diomyocytes ( 21 ) was also effective when assayed in our  C. 
elegans model. In mammalian systems, CYP eicosanoids 
probably act via both intracellular targets such as peroxisome-
proliferator activated receptors and membrane receptors 
that remain to be identifi ed ( 49, 60, 61 ). Considering the 
parallels between nematodes and mammalian systems 
revealed in the present study, we believe that  C. elegans 
provides a suitable model for elucidating evolutionary 
conserved mechanisms and key components of CYP-
eicosanoid signaling.  
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